13th Summit on Biosimilars & Innovator Biologics
The American Conference Institute invites you to attend the 13th Summit on Biosimilars & Innovator Biologics on June 28-29, 2022, back in-person in Boston! Gain government and industry insights on the Innovator and Biosimilars Marketplace from the U.S. FTC, USPTO, AAM, BIO and leading In-House Counsel.
We’ve reached an inflection point in the United States. With another major wave of loss of exclusivities of original biological medicines expected in the next five to ten years, it is imperative that industry is well prepared today. Now, more than ever, strategies to overcome these barriers are essential to improve the understanding of biosimilar products in the United States. The need for a solid guiding framework becomes more critical than ever before.
In this context, we cordially invite you to explore the contours of the rapidly changing landscape for biosimilars and innovator biologics. This June, join the “who’s who” of the biosimilars and innovator biologics industries as they gather in Boston for ACI’s 13th Annual Summit on Biosimilars & Innovator Biologics.
PLUS! PharmaShots Readers SAVE 10% with registration code: D10-658-658FX02
To Register:
- Website: https://bit.ly/3O1Xh6B
- Email: customerservice@americanconference.com
- Phone: 1-888-224-2480
Senior Editor at PharmaShots. She is curious and very passionate about recent updates and developments in the life sciences industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots.
